CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
CJ CheilJedang Corp., South Korea’s largest food and beverage company, said on Wednesday it has scrapped a planned sale of its green bio busin...
ABL Bio lands $2.8 billion license-out deal with GSK
ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-bas...
MBK Partners poised to acquire CJ Cheiljedang’s $3.5 billion bio business
North Asia-focused private equity firm MBK Partners is on the verge of clinching a major acquisition deal by offering a higher bid than other conten...
MBK Partners, 2 Chinese firms vie for CJ Cheiljedang’s $4 bn bio business
North Asia-focused private equity firm MBK Partners and two leading Chinese biotechnology firms are vying for management control of CJ Cheiljedang C...
Samsung Biologics signs initial deal with LigaChem Bio on ADC production
Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...
HD Hyundai Oilbank supplies bio VLSFO to Yangming
HD Hyundai Oilbank Co., a South Korean crude oil refiner backed by Saudi Aramco, said on Thursday it started to supply Taiwan-based Yang Ming Marine...
Blackstone, Carlyle, MBK vying for CJ CheilJedang’s bio business
Blackstone, Carlyle Group and MBK Partners have joined the race to purchase the bio business of CJ CheilJedang Corp., the world’s largest prod...
Latvian President Rinkēvičs seeks closer ties with S.Korea in bio, defense
Latvian President Edgars Rinkēvičs, who is on a four-day working trip to South Korea, said on Friday he hopes for deeper cooperation between the two...
CJ CheilJedang puts bio business on market for $4 bn
CJ CheilJedang Corp., South Korea’s largest food company, is seeking to sell its bio business for about 6 trillion won ($4.3 billion) in what ...
LG Chem targets functional cosmetics market with bio-materials
LG Chem Ltd., the world’s fourth-largest chemicals manufacturer, is targeting the functional cosmetics market with bio-materials derived from ...
Lotte to restructure bio business to focus on CDMO
South Korea’s retail-to-chemical conglomerate Lotte Group will restructure its bio business to focus on the profit-making medicine bio develop...
Korea's investment forum KIW 2024 kicks off September 9
South Korea’s largest investment forum Korea Investment Week 2024 (KIW 2024) will kick off next month in Seoul, drawing around 150 leaders fro...
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
HD Hyundai Oilbank exports bio marine fuel blends
The Korea Customs Service announced on July 29 that domestic petroleum products were exported after being blended in a bonded zone for the first tim...
LG to foster smart factory business as new B2B growth driver
PYEONGTAEK, Gyeonggi Province -- LG Electronics Inc., the leading global home appliance maker, aims to foster its smart factory business as a new gr...
Samsung Elec invests in US bio startup Element Biosciences
Samsung Electronics Co., the world’s top memory chipmaker, said on Friday it has invested in US biotech startup Element Biosciences Inc. to ex...
Samsung to invest $52 mn in US biotech VC Flagship Pioneering
Samsung C&T Corp., its bio units Samsung Biologics Co. and Samsung Bioepis Co. and Samsung Venture Investment Corp. have committed a combined 72...
PharmaResearch acquires TuringBio for digital therapeutics
PharmaResearch Co., a South Korean company specializing in regenerative medicine, announced on Wednesday that it acquired TuringBio, an AI-based dig...
Kwangdong Pharma acquires stake in Precision Bio
South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company...
Lotte Biologics targets $1.1 billion in sales with new bio plants
South Korean biopharmaceutical company Lotte Biologics Co. said on Wednesday it is aiming for 1.5 trillion won ($1.1 billion) in annual sales by 203...
PwC's Korean member taps new chiefs, creates finance unit
Samil PricewaterhouseCoopers (PwC), a South Korean member firm of PwC International Ltd., has appointed new chiefs of its key units and created a fi...
Samsung Biologics eyes windfall gain amid US-China row
SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...
Korean biotech Bertis to join BIO 2024 for global reach
South Korean biotech Bertis Inc. will deliver presentations at the BIO International Convention, one of the world’s largest bio and healthcare...
Korean biotech Xcell Therapeutics eyes June IPO
South Korean biotech Xcell Therapeutics Inc., a developer of chemically defined media for in vitro cell culture, is aiming for a junior bourse Kosda...
Samsung Life Science invests in US biotech firm Latus Bio
Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...
Daesung PE tops Korean venture funds by return in 2018-2023
Daesung Private Equity Inc. in South Korea has become the top local venture capital manager in terms of realized capital gain between 2018 and 2023,...
Bio startup ArtBlood attracts $4.8 mn investment
South Korean bio startup ArtBlood, specializing in blood production for transfusion, announced on Tuesday that it successfully secured an investment...
Hyosung TNC to invest $1 bn in new bio-fiber plants in Vietnam
Hyosung TNC Corp., the world’s top spandex maker, plans to invest $1 billion in new bio-textile materials plants in Vietnam to accelerate its ...
Samsung begins new drug development for rare diseases
Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...
Samsung invests in BrickBio in US
Samsung Group announced on Tuesday that its Life Science Fund has invested in the US-based antibody-drug conjugates (ADC) and gene therapy technol...
